Tag: Cancer: Breast

CWI has no impact on overall survival at 10 years among patients with intermediate-risk breast cancer

Findings show survival benefits for both risk-reducing mastectomy and salpingo-oophorectomy

Omission noninferior to sentinel-lymph-node biopsy for clinically node-negative early-stage invasive breast cancer

Two-year cumulative rate of invasive ipsilateral breast cancer 5.9 and 4.2 percent for guideline-concordant care, active monitoring

Addition of camrelizumab improves pathological complete response in early or locally advanced triple negative breast cancer

Higher increase in rates over time seen for Black and Asian patients versus White patients and for Medicaid, Medicare patients

Imlunestrant leads to significantly longer progression-free survival among those with ESR1 mutations, but not in overall population

Significant increase seen in incidence rates at presentation for women overall, and for those aged 20 to 39, 40 to 74, and 75 years or older

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM

Five-year AUC with addition of previous mammogram images improves current visit mammogram AUC